Psoriatic Arthritis & Heel Spurs: Metabolic Syndrome Link
Uncover a critical link: metabolic syndrome significantly impacts those with psoriatic arthritis. Research reveals over half of these patients grapple with metabolic syndrome, fostering spinal and entheses issues. Modifying this connection can bring real benefits. Highlighting its profound impact, this article from News Directory 3 details how syndrome influences calcaneal spurs, diffuse idiopathic skeletal hyperostosis, and degenerative disc disease. While no direct link to radiographic damage was found, the implications for long-term health are clear. Learn how to modify the risk profile. Discover what’s next …
Metabolic syndrome a Modifiable Risk Factor in Psoriatic Arthritis
Updated June 17, 2025
More than 58% of individuals with psoriatic arthritis (PsA) are affected by metabolic syndrome, which correlates with degenerative and metabolic changes in the spine and entheses, according to research in Arthritis Care & Research.
Dr. Fadi Kharouf, a clinical research fellow at the Gladman Krembil-Psoriatic Arthritis Research Program at Toronto Western Hospital, stated that metabolic syndrome, a cluster of risk factors including obesity, high blood pressure, elevated blood sugar, and abnormal cholesterol, is commonly observed in patients with psoriatic disease. The evolving understanding of the connection between metabolic syndrome, obesity, and rheumatologic disorders highlights the importance of addressing metabolic syndrome in clinical practice, according to rheumatologists.
The pro-inflammatory state of metabolic syndrome can be modified to benefit patients.Modifying metabolic syndrome and obesity in rheumatologic patients has significant consequences, experts say.
The study indicated that metabolic syndrome was associated with calcaneal spurs, diffuse idiopathic skeletal hyperostosis, and degenerative disc disease in PsA patients. Though, it was not linked to radiographic axial or peripheral damage.
What’s next
Further research is needed to fully understand the mechanisms by which metabolic syndrome influences the progression of psoriatic arthritis and to develop targeted interventions.